Company Directory - AISAP
Company Details - AISAP
AISAP
WebsiteAISAP is known for delivering integrated health solutions and services leveraging technology to enhance patient outcomes.
CCI Score
CCI Score: AISAP
57.39
-0.04%
Latest Event
FDA Clearance for AISAP CARDIO Software
AISAP received 510(k) clearance from the FDA for its innovative AI-powered cardiac ultrasound software platform, AISAP CARDIO, which integrates multiple diagnostic modules for real-time, point-of-care cardiac assessments.
Take Action
So what can you do? Support AISAP by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
LEADER
AISAP is currently rated as a Leader.
Latest Events
- AUG252024
AISAP received 510(k) clearance from the FDA for its innovative AI-powered cardiac ultrasound software platform, AISAP CARDIO, which integrates multiple diagnostic modules for real-time, point-of-care cardiac assessments.
+65
Business Practices and Ethical Responsibility
March 28
The FDA clearance demonstrates AISAP's adherence to high safety and ethical standards, reinforcing responsible business practices in healthcare technology. This regulatory approval signifies that the company's product meets stringent quality criteria, indirectly supporting patient well-being and equitable healthcare delivery.
FDA Clears Israel’s AISAP’s AI-Powered Cardiac Ultrasound Software for Point-of-Care Diagnosis
+80
Technology and Services Impact
March 28
The AISAP CARDIO platform leverages advanced AI technology to enhance the accuracy and speed of cardiac diagnosis, making cutting-edge healthcare more accessible. This innovative approach has the potential to transform patient care, particularly by empowering frontline clinicians and benefiting underrepresented communities.
FDA Clears Israel’s AISAP’s AI-Powered Cardiac Ultrasound Software for Point-of-Care Diagnosis
- AUG222024
AISAP announced that its AI-powered CARDIO ultrasound diagnostic platform received FDA 510(k) clearance, marking a significant achievement in advancing point-of-care ultrasound diagnostics that can enhance patient outcomes.
+50
Technology and Services Impact
March 28
The FDA clearance of AISAP's CARDIO platform highlights a breakthrough in healthcare technology, improving diagnostic accessibility and accuracy. This innovation supports better patient care and reflects positively on technology and services impact, aligning with broader social benefits and ethical innovation in healthcare.
AISAP’s CARDIO AI-powered point-of-care ultrasound diagnostic software receives FDA clearance